Associated Papers
Genetic polymorphisms of PPAR genes and human cancers: evidence for gene-environment interactions.
Dhaini HR et al.
Journal of Environmental Science and Health. Part C, Environmental Carcinogenesis & Ecotoxicology Reviews, 2019
Association of peroxisome proliferator-activated receptorγ gene Pro12Ala and C161T polymorphisms with cardiovascular risk factors in maintenance hemodialysis patients.
Liu F et al.
Molecular Biology Reports, 2014
Combined effects of the C161T and Pro12Ala PPARγ2 gene variants with insulin resistance on metabolic syndrome: a case-control study of a central Tunisian population.
Youssef SM et al.
Journal of Molecular Neuroscience : Mn, 2014
Association of peroxisome proliferator-activated receptor γ polymorphisms and haplotypes with essential hypertension.
Gu SJ et al.
Genetic Testing and Molecular Biomarkers, 2013
Association of peroxisome proliferator activated receptor-γ gene with non-alcoholic fatty liver disease in Asian Indians residing in north India.
Bhatt SP et al.
Gene, 2013
[Genotype and haplotype analysis of peroxisome proliferators activated receptor α gene and the risk of essential hypertension].
Ding Y et al.
Zhonghua Yi Xue Za Zhi, 2012
The C-681G polymorphism of the PPAR-γ gene is associated with susceptibility to non-alcoholic fatty liver disease.
Cao CY et al.
The Tohoku Journal of Experimental Medicine, 2012
Gender differences in the effects of peroxisome proliferator-activated receptor γ2 gene polymorphisms on metabolic adversity in patients with schizophrenia or schizoaffective disorder.
Chen CH et al.
Progress in Neuro-psychopharmacology & Biological Psychiatry, 2011
Peroxisome proliferator-activated receptor-gamma gene polymorphism and risk of cardiovascular disease in patients with diabetic nephropathy.
Szeto CC et al.
American Journal of Nephrology, 2008
PPARgamma gene C161T substitution is associated with reduced risk of coronary artery disease and decreased proinflammatory cytokine expression.
Liu Y et al.
American Heart Journal, 2007
Meat, milk, saturated fatty acids, the Pro12Ala and C161T polymorphisms of the PPARgamma gene and colorectal cancer risk in Japanese.
Kuriki K et al.
Cancer Science, 2006
Genetic polymorphisms in peroxisome proliferator-activated receptor gamma are associated with Type 2 diabetes mellitus and obesity in the Korean population.
Moon MK et al.
Diabetic Medicine : a Journal of the British Diabetic Association, 2005
Influence of the C161T but not Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma on colorectal cancer in an Indian population.
Jiang J et al.
Cancer Science, 2005
Effect of the peroxisome proliferator activated receptor-gamma gene Pro12Ala variant on body mass index: a meta-analysis.
Masud S et al.
Journal of Medical Genetics, 2003
[Association of Pro12Ala variant in peroxisome proliferator-activated receptor-gamma2 gene with type 2 diabetes mellitus].
Fu M et al.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics, 2002
Lack of association between peroxisome proliferator-activated receptor-gamma-2 gene variants and the occurrence of coronary heart disease in patients with diabetes mellitus.
Blüher M et al.
European Journal of Endocrinology, 2002
No association between peroxisome proliferator-activated receptor and uncoupling protein gene polymorphisms and obesity in Malaysian university students.
Yiew SK et al.
Obesity Research & Clinical Practice, 0
Peroxisome Proliferator-Activated Receptor α and γ Gene Polymorphisms among South Indian Patients with Diabetic Dyslipidaemia.
Bage IJ et al.
Indian Journal of Endocrinology and Metabolism, 0